Articles tagged with Biosensors
The LEADERS study demonstrated that Biosensors DES is non-inferior to Cypher DES in terms of clinical events, stent thrombosis rates and angiographic follow-up data. The trial included a broad range of patients with symptomatic coronary disease, reflecting routine clinical practice.
Magnet Lab researchers develop two new biosensors to monitor cellular dynamics and expand optical microscopy capabilities. The new technique enables the observation of two dynamic processes in a single cell for longer periods, speeding up experiments and advancing tumor and developmental biology research.
Researchers have developed a new MRI technique that combines high temperatures with hyperpolarized xenon to create a supersensitive diagnostic system. The method, called Hyper-CEST MRI, allows for faster and more selective imaging of specific target molecules, such as tumors in human subjects.
A portable DNA sequencer could aid environmental scientists, clinicians, and medical researchers in detecting genetic disorders. A new type of electronic device, the ion-selective field-effect transistor (ISFET), is being integrated into a DNA biosensor to measure changes in conductivity.
Researchers have created fluorogen activating proteins (FAPs) that enable biologists to monitor biological activities of individual proteins in living cells in real time. The FAPs allow for simple and direct tracking of proteins on the cell surface and within living cells, eliminating cumbersome experimental steps.
Researchers have designed novel peptide sequences that can detect oxidation and reduction inside cells, providing a new tool for understanding molecular mechanisms underlying complex biomedical problems. The biosensors use Förster resonance energy transfer (FRET) to measure redox potentials and oxidative stress in live cells.
Scientists at PNNL have developed a portable biosensor that can distinguish between individuals exposed to nerve agents and those who are simply scared. The sensor uses nano-based technology to amplify biomarker signals, enabling precise readings and faster detection.
Clemson University receives funding for developing an implantable biochip that can relay vital health information in emergencies. The device has potential applications in trauma care, space exploration and monitoring of diseases such as diabetes.
Scientists at Universitat Autonoma de Barcelona developed a new electro-chemical biosensor that detects pesticides and antibiotics in food with high sensitivity and portability. The sensor can detect levels of atrazine and sulphanilamides below maximum allowed concentrations, making it easier to control food safety.
Researchers at Temple University have developed a new biosensor that uses mammalian olfactory signaling machinery to detect explosives. The biosensor can also potentially be used to screen experimental medications, a crucial step in the development of new drugs.
Researchers created a biosensor using quantum dots to mimic the clustering of MHC proteins on target cells, revealing strong contributions from non-viral peptide-MHC interaction with co-receptors. This cooperativity suggests that a single virus-MHC complex recognized in self-MHC complexes can activate a T-cell response.
Researchers developed a new technique called HYPER-CEST for Magnetic Resonance Imaging that can detect molecules at lower concentrations, enabling better medical diagnosis and treatment. This method uses hyperpolarized xenon signals to generate highly selective contrast and provides both spatial and biochemical information.
Hopkins researchers have created a biosensor that allows them to see multiple, real-time chemical reactions in living cells. The sensor can locate where an enzyme is being turned on or off within the cell, providing valuable insights into how chemicals interact with enzymes.
The National Technology Center for Networks and Pathways will develop fluorescent probe technologies to investigate real-time interactions in living cells. This work aims to generate molecular biosensors for preclinical research, ultimately improving hospital-based diagnostic medicine.
Kent State and NEOUCOM researchers developed liquid crystal biosensor technology to quickly detect harmful pathogens. This technology has the potential to diagnose infectious diseases within minutes, enhancing health, safety, and economic vitality in Ohio communities and the nation.
A new biosensor developed by GeneFluidics enables accurate identification of bacteria in urine samples with a rapid turnaround time, reducing the two-day wait period for conventional lab tests. This innovation has the potential to improve patient outcomes and reduce healthcare costs associated with urinary tract infections.
The Air Force has developed a portable biosensor system that can detect and identify biological warfare agents. The system, consisting of a spray and a hand-held 'green box,' provides rapid detection capability and is designed to be reliable, disposable, and cost-effective.
A team of Purdue chemists has found that amines can form stable bonds with gold surfaces, making them suitable for coating sensors and other devices. This discovery could expand the range of molecules used in biotech applications, particularly in biosensors that detect proteins in the blood to indicate disease.
Researchers at ASU have developed a novel method to detect DNA mutations using nanocrystals that can recognize subtle changes in DNA. This technology has the potential to diagnose genetic diseases, detect infectious agents, and provide reliable forensic analysis.
Researchers have created a surface that can align liquid-crystal molecules, enabling the construction of LCDs and opening up the possibility of biosensors. The aligned liquid crystals can detect the presence of certain types of DNA without additional equipment.
Purdue researchers develop a new optical biosensor that can detect minute quantities of Listeria monocytogenes in less than 24 hours. The sensor is selective enough to recognize only the species monocytogenes and has improved detection capabilities compared to existing commercial test kits.
The von Liebig Center has awarded six grants totaling $1.2 million to UC San Diego faculty for commercializing their research. These grants support projects in various fields, including bioengineering, computer science and engineering, electrical and computer engineering, and mechanical aerospace engineering.
Researchers have discovered an imaging technique that monitors cancer cell proliferation by incorporating fluorescent proteins into cell nuclei. The technique allows for simultaneous observation of up to 100 cells and can be used to screen compound libraries for novel anti-cancer therapies.
The UGA team will expand on their glancing angle deposition technique to fabricate nanoscale 3-D pillars, providing unique features for biosensing applications. The project aims to solve pressing health-related problems through interdisciplinary research and cooperation.
Researchers at University of Illinois have developed a highly sensitive and selective biosensor that uses DNA-gold nanoparticle chemistry to detect lead and other metal ions. The colorimetric sensor can be tuned for different contaminant concentrations, making it suitable for on-site detection.
Researchers from the University of Delaware have developed a cheap and disposable biosensor using gold-on-plastic technology, which can detect targeted molecules in bodily fluids with high accuracy. The device is more specific than existing methods, such as latex agglutination tests, and can be produced at a lower cost.
A portable, hand-held biosensor has been developed to detect a wide range of medically important chemical compounds. The device, capable of detecting tiny concentrations of specific molecules, may represent a new type of practical and affordable device for various medical applications.